【市場調査レポート】粘液線毛クリアランス＆機能不全治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Mucociliary Clearance and Dysfunction Treatment Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。粘液線毛クリアランス＆機能不全治療のグローバル市場インサイト・予測（～2028年） / Global Mucociliary Clearance and Dysfunction Treatment Market Insights, Forecast to 2028 / QY2207E09255資料のイメージです。

• レポートコード：QY2207E09255
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、119ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の粘液線毛クリアランス＆機能不全治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に粘液線毛クリアランス＆機能不全治療の世界市場のxxx％を占める「薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の粘液線毛クリアランス＆機能不全治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの粘液線毛クリアランス＆機能不全治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの粘液線毛クリアランス＆機能不全治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

粘液線毛クリアランス＆機能不全治療のグローバル主要メーカーには、Vortran Medical Technology、Smiths Group、Monaghan、Hill-Rom Services、Allergan、Novartis、AstraZeneca、Merck、Regeneron Pharmaceuticals、Abbott、F. Hoffmann-La Roche、Cadila Pharmaceuticals、Eisai、Cipla、Glenmark Pharmaceuticals Limited、Vertical Pharmaceuticals、TORAY INDUSTRIES、Pfizerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

粘液線毛クリアランス＆機能不全治療市場は、種類と用途によって区分されます。世界の粘液線毛クリアランス＆機能不全治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
薬品、手術、粘液クリアランス装置、その他

【用途別セグメント】
病院、専門クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 粘液線毛クリアランス＆機能不全治療製品概要
- 種類別市場（薬品、手術、粘液クリアランス装置、その他）
- 用途別市場（病院、専門クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の粘液線毛クリアランス＆機能不全治療販売量予測2017-2028
- 世界の粘液線毛クリアランス＆機能不全治療売上予測2017-2028
- 粘液線毛クリアランス＆機能不全治療の地域別販売量
- 粘液線毛クリアランス＆機能不全治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別粘液線毛クリアランス＆機能不全治療販売量
- 主要メーカー別粘液線毛クリアランス＆機能不全治療売上
- 主要メーカー別粘液線毛クリアランス＆機能不全治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（薬品、手術、粘液クリアランス装置、その他）
- 粘液線毛クリアランス＆機能不全治療の種類別販売量
- 粘液線毛クリアランス＆機能不全治療の種類別売上
- 粘液線毛クリアランス＆機能不全治療の種類別価格
・用途別市場規模（病院、専門クリニック、その他）
- 粘液線毛クリアランス＆機能不全治療の用途別販売量
- 粘液線毛クリアランス＆機能不全治療の用途別売上
- 粘液線毛クリアランス＆機能不全治療の用途別価格
・北米市場
- 北米の粘液線毛クリアランス＆機能不全治療市場規模（種類別、用途別）
- 主要国別の粘液線毛クリアランス＆機能不全治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの粘液線毛クリアランス＆機能不全治療市場規模（種類別、用途別）
- 主要国別の粘液線毛クリアランス＆機能不全治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の粘液線毛クリアランス＆機能不全治療市場規模（種類別、用途別）
- 主要国別の粘液線毛クリアランス＆機能不全治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の粘液線毛クリアランス＆機能不全治療市場規模（種類別、用途別）
- 主要国別の粘液線毛クリアランス＆機能不全治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの粘液線毛クリアランス＆機能不全治療市場規模（種類別、用途別）
- 主要国別の粘液線毛クリアランス＆機能不全治療市場規模（トルコ、サウジアラビア）
・企業情報
Vortran Medical Technology、Smiths Group、Monaghan、Hill-Rom Services、Allergan、Novartis、AstraZeneca、Merck、Regeneron Pharmaceuticals、Abbott、F. Hoffmann-La Roche、Cadila Pharmaceuticals、Eisai、Cipla、Glenmark Pharmaceuticals Limited、Vertical Pharmaceuticals、TORAY INDUSTRIES、Pfizer
・産業チェーン及び販売チャネル分析
- 粘液線毛クリアランス＆機能不全治療の産業チェーン分析
- 粘液線毛クリアランス＆機能不全治療の原材料
- 粘液線毛クリアランス＆機能不全治療の生産プロセス
- 粘液線毛クリアランス＆機能不全治療の販売及びマーケティング
- 粘液線毛クリアランス＆機能不全治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 粘液線毛クリアランス＆機能不全治療の産業動向
- 粘液線毛クリアランス＆機能不全治療のマーケットドライバー
- 粘液線毛クリアランス＆機能不全治療の課題
- 粘液線毛クリアランス＆機能不全治療の阻害要因
・主な調査結果

Mucociliary dysfunction is a common sign of chronic obstructive pulmonary disease. Mucociliary clearance is a well-known innate defense system against microbes and irritants inhaled through the nose. The Saccharine Test in the sino-nasal system can be used to assess mucociliary clearance. The therapy for mucociliary clearance generally includes proteolytic enzymes to reduce mucus viscosity, vibrations for improving ciliary beat frequency, irrigation with Locke-Ringer’s solution for cilia frequency, glucosteroids and surfactants.
Market Analysis and Insights: Global Mucociliary Clearance and Dysfunction Treatment Market
The global Mucociliary Clearance and Dysfunction Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Medications accounting for % of the Mucociliary Clearance and Dysfunction Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Mucociliary Clearance and Dysfunction Treatment market size is valued at US$ million in 2021, while the North America and Europe Mucociliary Clearance and Dysfunction Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mucociliary Clearance and Dysfunction Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mucociliary Clearance and Dysfunction Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mucociliary Clearance and Dysfunction Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mucociliary Clearance and Dysfunction Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mucociliary Clearance and Dysfunction Treatment market.
Global Mucociliary Clearance and Dysfunction Treatment Scope and Market Size
Mucociliary Clearance and Dysfunction Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Mucociliary Clearance and Dysfunction Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Medications
Surgery
Mucus Clearance Device
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Company
Vortran Medical Technology
Smiths Group
Monaghan
Hill-Rom Services
Allergan
Novartis
AstraZeneca
Merck
Regeneron Pharmaceuticals
Abbott
F. Hoffmann-La Roche
Cadila Pharmaceuticals
Eisai
Cipla
Glenmark Pharmaceuticals Limited
Vertical Pharmaceuticals
TORAY INDUSTRIES
Pfizer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mucociliary Clearance and Dysfunction Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medications
1.2.3 Surgery
1.2.4 Mucus Clearance Device
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mucociliary Clearance and Dysfunction Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mucociliary Clearance and Dysfunction Treatment Market Perspective (2017-2028)
2.2 Mucociliary Clearance and Dysfunction Treatment Growth Trends by Region
2.2.1 Mucociliary Clearance and Dysfunction Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mucociliary Clearance and Dysfunction Treatment Historic Market Size by Region (2017-2022)
2.2.3 Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Region (2023-2028)
2.3 Mucociliary Clearance and Dysfunction Treatment Market Dynamics
2.3.1 Mucociliary Clearance and Dysfunction Treatment Industry Trends
2.3.2 Mucociliary Clearance and Dysfunction Treatment Market Drivers
2.3.3 Mucociliary Clearance and Dysfunction Treatment Market Challenges
2.3.4 Mucociliary Clearance and Dysfunction Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mucociliary Clearance and Dysfunction Treatment Players by Revenue
3.1.1 Global Top Mucociliary Clearance and Dysfunction Treatment Players by Revenue (2017-2022)
3.1.2 Global Mucociliary Clearance and Dysfunction Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Mucociliary Clearance and Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mucociliary Clearance and Dysfunction Treatment Revenue
3.4 Global Mucociliary Clearance and Dysfunction Treatment Market Concentration Ratio
3.4.1 Global Mucociliary Clearance and Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mucociliary Clearance and Dysfunction Treatment Revenue in 2021
3.5 Mucociliary Clearance and Dysfunction Treatment Key Players Head office and Area Served
3.6 Key Players Mucociliary Clearance and Dysfunction Treatment Product Solution and Service
3.7 Date of Enter into Mucociliary Clearance and Dysfunction Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mucociliary Clearance and Dysfunction Treatment Breakdown Data by Type
4.1 Global Mucociliary Clearance and Dysfunction Treatment Historic Market Size by Type (2017-2022)
4.2 Global Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Type (2023-2028)
5 Mucociliary Clearance and Dysfunction Treatment Breakdown Data by Application
5.1 Global Mucociliary Clearance and Dysfunction Treatment Historic Market Size by Application (2017-2022)
5.2 Global Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
6.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type
6.2.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
6.2.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
6.2.3 North America Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
6.3 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application
6.3.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
6.3.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
6.3.3 North America Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
6.4 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country
6.4.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
6.4.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
7.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type
7.2.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
7.2.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
7.2.3 Europe Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
7.3 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application
7.3.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
7.3.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
7.3.3 Europe Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
7.4 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country
7.4.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
7.4.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
8.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type
8.2.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application
8.3.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region
8.4.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
9.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type
9.2.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
9.3 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application
9.3.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
9.4 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country
9.4.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
10.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type
10.2.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application
10.3.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country
10.4.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Vortran Medical Technology
11.1.1 Vortran Medical Technology Company Details
11.1.2 Vortran Medical Technology Business Overview
11.1.3 Vortran Medical Technology Mucociliary Clearance and Dysfunction Treatment Introduction
11.1.4 Vortran Medical Technology Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.1.5 Vortran Medical Technology Recent Developments
11.2 Smiths Group
11.2.1 Smiths Group Company Details
11.2.2 Smiths Group Business Overview
11.2.3 Smiths Group Mucociliary Clearance and Dysfunction Treatment Introduction
11.2.4 Smiths Group Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.2.5 Smiths Group Recent Developments
11.3 Monaghan
11.3.1 Monaghan Company Details
11.3.2 Monaghan Business Overview
11.3.3 Monaghan Mucociliary Clearance and Dysfunction Treatment Introduction
11.3.4 Monaghan Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.3.5 Monaghan Recent Developments
11.4 Hill-Rom Services
11.4.1 Hill-Rom Services Company Details
11.4.2 Hill-Rom Services Business Overview
11.4.3 Hill-Rom Services Mucociliary Clearance and Dysfunction Treatment Introduction
11.4.4 Hill-Rom Services Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.4.5 Hill-Rom Services Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Mucociliary Clearance and Dysfunction Treatment Introduction
11.5.4 Allergan Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.5.5 Allergan Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Mucociliary Clearance and Dysfunction Treatment Introduction
11.6.4 Novartis Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Mucociliary Clearance and Dysfunction Treatment Introduction
11.7.4 AstraZeneca Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Mucociliary Clearance and Dysfunction Treatment Introduction
11.8.4 Merck Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Details
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.9.5 Regeneron Pharmaceuticals Recent Developments
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Mucociliary Clearance and Dysfunction Treatment Introduction
11.10.4 Abbott Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.10.5 Abbott Recent Developments
11.11 F. Hoffmann-La Roche
11.11.1 F. Hoffmann-La Roche Company Details
11.11.2 F. Hoffmann-La Roche Business Overview
11.11.3 F. Hoffmann-La Roche Mucociliary Clearance and Dysfunction Treatment Introduction
11.11.4 F. Hoffmann-La Roche Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.11.5 F. Hoffmann-La Roche Recent Developments
11.12 Cadila Pharmaceuticals
11.12.1 Cadila Pharmaceuticals Company Details
11.12.2 Cadila Pharmaceuticals Business Overview
11.12.3 Cadila Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Introduction
11.12.4 Cadila Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.12.5 Cadila Pharmaceuticals Recent Developments
11.13 Eisai
11.13.1 Eisai Company Details
11.13.2 Eisai Business Overview
11.13.3 Eisai Mucociliary Clearance and Dysfunction Treatment Introduction
11.13.4 Eisai Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.13.5 Eisai Recent Developments
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Mucociliary Clearance and Dysfunction Treatment Introduction
11.14.4 Cipla Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.14.5 Cipla Recent Developments
11.15 Glenmark Pharmaceuticals Limited
11.15.1 Glenmark Pharmaceuticals Limited Company Details
11.15.2 Glenmark Pharmaceuticals Limited Business Overview
11.15.3 Glenmark Pharmaceuticals Limited Mucociliary Clearance and Dysfunction Treatment Introduction
11.15.4 Glenmark Pharmaceuticals Limited Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.15.5 Glenmark Pharmaceuticals Limited Recent Developments
11.16 Vertical Pharmaceuticals
11.16.1 Vertical Pharmaceuticals Company Details
11.16.2 Vertical Pharmaceuticals Business Overview
11.16.3 Vertical Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Introduction
11.16.4 Vertical Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.16.5 Vertical Pharmaceuticals Recent Developments
11.17 TORAY INDUSTRIES
11.17.1 TORAY INDUSTRIES Company Details
11.17.2 TORAY INDUSTRIES Business Overview
11.17.3 TORAY INDUSTRIES Mucociliary Clearance and Dysfunction Treatment Introduction
11.17.4 TORAY INDUSTRIES Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.17.5 TORAY INDUSTRIES Recent Developments
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Mucociliary Clearance and Dysfunction Treatment Introduction
11.18.4 Pfizer Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.18.5 Pfizer Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Mucociliary Clearance and Dysfunction Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Medications
Table 3. Key Players of Surgery
Table 4. Key Players of Mucus Clearance Device
Table 5. Key Players of Others
Table 6. Global Mucociliary Clearance and Dysfunction Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Mucociliary Clearance and Dysfunction Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Mucociliary Clearance and Dysfunction Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Mucociliary Clearance and Dysfunction Treatment Market Share by Region (2017-2022)
Table 10. Global Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Mucociliary Clearance and Dysfunction Treatment Market Share by Region (2023-2028)
Table 12. Mucociliary Clearance and Dysfunction Treatment Market Trends
Table 13. Mucociliary Clearance and Dysfunction Treatment Market Drivers
Table 14. Mucociliary Clearance and Dysfunction Treatment Market Challenges
Table 15. Mucociliary Clearance and Dysfunction Treatment Market Restraints
Table 16. Global Mucociliary Clearance and Dysfunction Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Mucociliary Clearance and Dysfunction Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Mucociliary Clearance and Dysfunction Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucociliary Clearance and Dysfunction Treatment as of 2021)
Table 19. Ranking of Global Top Mucociliary Clearance and Dysfunction Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Mucociliary Clearance and Dysfunction Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mucociliary Clearance and Dysfunction Treatment Product Solution and Service
Table 23. Date of Enter into Mucociliary Clearance and Dysfunction Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Mucociliary Clearance and Dysfunction Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Mucociliary Clearance and Dysfunction Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Mucociliary Clearance and Dysfunction Treatment Revenue Share by Application (2017-2022)
Table 31. Global Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Mucociliary Clearance and Dysfunction Treatment Revenue Share by Application (2023-2028)
Table 33. North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Vortran Medical Technology Company Details
Table 64. Vortran Medical Technology Business Overview
Table 65. Vortran Medical Technology Mucociliary Clearance and Dysfunction Treatment Product
Table 66. Vortran Medical Technology Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 67. Vortran Medical Technology Recent Developments
Table 68. Smiths Group Company Details
Table 69. Smiths Group Business Overview
Table 70. Smiths Group Mucociliary Clearance and Dysfunction Treatment Product
Table 71. Smiths Group Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 72. Smiths Group Recent Developments
Table 73. Monaghan Company Details
Table 74. Monaghan Business Overview
Table 75. Monaghan Mucociliary Clearance and Dysfunction Treatment Product
Table 76. Monaghan Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 77. Monaghan Recent Developments
Table 78. Hill-Rom Services Company Details
Table 79. Hill-Rom Services Business Overview
Table 80. Hill-Rom Services Mucociliary Clearance and Dysfunction Treatment Product
Table 81. Hill-Rom Services Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 82. Hill-Rom Services Recent Developments
Table 83. Allergan Company Details
Table 84. Allergan Business Overview
Table 85. Allergan Mucociliary Clearance and Dysfunction Treatment Product
Table 86. Allergan Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 87. Allergan Recent Developments
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Mucociliary Clearance and Dysfunction Treatment Product
Table 91. Novartis Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 92. Novartis Recent Developments
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Mucociliary Clearance and Dysfunction Treatment Product
Table 96. AstraZeneca Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 97. AstraZeneca Recent Developments
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Mucociliary Clearance and Dysfunction Treatment Product
Table 101. Merck Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 102. Merck Recent Developments
Table 103. Regeneron Pharmaceuticals Company Details
Table 104. Regeneron Pharmaceuticals Business Overview
Table 105. Regeneron Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Product
Table 106. Regeneron Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 107. Regeneron Pharmaceuticals Recent Developments
Table 108. Abbott Company Details
Table 109. Abbott Business Overview
Table 110. Abbott Mucociliary Clearance and Dysfunction Treatment Product
Table 111. Abbott Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 112. Abbott Recent Developments
Table 113. F. Hoffmann-La Roche Company Details
Table 114. F. Hoffmann-La Roche Business Overview
Table 115. F. Hoffmann-La Roche Mucociliary Clearance and Dysfunction Treatment Product
Table 116. F. Hoffmann-La Roche Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 117. F. Hoffmann-La Roche Recent Developments
Table 118. Cadila Pharmaceuticals Company Details
Table 119. Cadila Pharmaceuticals Business Overview
Table 120. Cadila Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Product
Table 121. Cadila Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 122. Cadila Pharmaceuticals Recent Developments
Table 123. Eisai Company Details
Table 124. Eisai Business Overview
Table 125. Eisai Mucociliary Clearance and Dysfunction Treatment Product
Table 126. Eisai Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 127. Eisai Recent Developments
Table 128. Cipla Company Details
Table 129. Cipla Business Overview
Table 130. Cipla Mucociliary Clearance and Dysfunction Treatment Product
Table 131. Cipla Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 132. Cipla Recent Developments
Table 133. Glenmark Pharmaceuticals Limited Company Details
Table 134. Glenmark Pharmaceuticals Limited Business Overview
Table 135. Glenmark Pharmaceuticals Limited Mucociliary Clearance and Dysfunction Treatment Product
Table 136. Glenmark Pharmaceuticals Limited Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 137. Glenmark Pharmaceuticals Limited Recent Developments
Table 138. Vertical Pharmaceuticals Company Details
Table 139. Vertical Pharmaceuticals Business Overview
Table 140. Vertical Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Product
Table 141. Vertical Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 142. Vertical Pharmaceuticals Recent Developments
Table 143. TORAY INDUSTRIES Company Details
Table 144. TORAY INDUSTRIES Business Overview
Table 145. TORAY INDUSTRIES Mucociliary Clearance and Dysfunction Treatment Product
Table 146. TORAY INDUSTRIES Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 147. TORAY INDUSTRIES Recent Developments
Table 148. Pfizer Company Details
Table 149. Pfizer Business Overview
Table 150. Pfizer Mucociliary Clearance and Dysfunction Treatment Product
Table 151. Pfizer Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022) & (US$ Million)
Table 152. Pfizer Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mucociliary Clearance and Dysfunction Treatment Market Share by Type: 2021 VS 2028
Figure 2. Medications Features
Figure 3. Surgery Features
Figure 4. Mucus Clearance Device Features
Figure 5. Others Features
Figure 6. Global Mucociliary Clearance and Dysfunction Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Mucociliary Clearance and Dysfunction Treatment Report Years Considered
Figure 11. Global Mucociliary Clearance and Dysfunction Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Mucociliary Clearance and Dysfunction Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Mucociliary Clearance and Dysfunction Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Mucociliary Clearance and Dysfunction Treatment Market Share by Players in 2021
Figure 15. Global Top Mucociliary Clearance and Dysfunction Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucociliary Clearance and Dysfunction Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Mucociliary Clearance and Dysfunction Treatment Revenue in 2021
Figure 17. North America Mucociliary Clearance and Dysfunction Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Mucociliary Clearance and Dysfunction Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Mucociliary Clearance and Dysfunction Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Mucociliary Clearance and Dysfunction Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Mucociliary Clearance and Dysfunction Treatment Market Size Share by Region (2017-2028)
Figure 37. China Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Mucociliary Clearance and Dysfunction Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Mucociliary Clearance and Dysfunction Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Mucociliary Clearance and Dysfunction Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Vortran Medical Technology Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 57. Smiths Group Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 58. Monaghan Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 59. Hill-Rom Services Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 60. Allergan Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 63. Merck Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 64. Regeneron Pharmaceuticals Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 65. Abbott Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 67. Cadila Pharmaceuticals Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 68. Eisai Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 69. Cipla Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 70. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 71. Vertical Pharmaceuticals Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 72. TORAY INDUSTRIES Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 73. Pfizer Revenue Growth Rate in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

勃起不全用薬のグローバル市場インサイト・予測（～2028年）

Global Erectile Dysfunction Medicine Market Insights, Forecast to 2028
QY2207C3822 2022年7月11日 114Pages
新型コロナウイルス感染症のパンデミックにより、世界の勃起不全用薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に勃起不全用薬の世界市場の...

勃起不全真空収縮装置のグローバル市場インサイト・予測（～2028年）

Global Erectile Dysfunction Vacuum Constriction Device Market Insights, Forecast to 2028
QY2207C3570 2022年7月11日 94Pages
新型コロナウイルス感染症のパンデミックにより、世界の勃起不全真空収縮装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に勃起不全真空収縮...

勃起不全（ED）装置のグローバル市場インサイト・予測（～2028年）

Global Erectile Dysfunction (ED) Devices Market Insights, Forecast to 2028
QY2207C3569 2022年7月11日 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の勃起不全（ED）装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に勃起不全（ED）...

世界の勃起不全ESWTユニット市場予測（～2028年）：移動式、固定式

Global Erectile Dysfunction ESWT Units Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E7875 2022年5月 94Pages
勃起不全ESWTユニット市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供し...

非感染性ブドウ膜炎治療のグローバル市場インサイト・予測（～2028年）

Global Non-infectious Uveitis Treatment Market Insights, Forecast to 2028
QY2207E09261 2022年7月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の非感染性ブドウ膜炎治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に非感染性ブドウ...

勃起不全真空収縮装置のグローバル市場インサイト・予測（～2028年） A vacuum constriction device (VCD, or a penis pump) helps a man get and keep an erection. Usually used for medical causes of erectile dysfunction, a VCD can also help men with anxiety-based ED. Market Analysis and Insights: Global Erectile Dysfunction Vacuum Constriction Device Market Due to the COV…
世界の勃起不全真空収縮装置市場予測（～2028年）：手動、自動 The Erectile Dysfunction Vacuum Constriction Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
勃起不全（ED）装置のグローバル市場インサイト・予測（～2028年） Erectile dysfunction (or impotence) is when you cannot get or keep an erection that enables you to have sex. Market Analysis and Insights: Global Erectile Dysfunction (ED) Devices Market Due to the COVID-19 pandemic, the global Erectile Dysfunction (ED) Devices market size is estimated to be worth U…
勃起不全用薬のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Erectile Dysfunction Medicine Market Due to the COVID-19 pandemic, the global Erectile Dysfunction Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast p…
世界の勃起不全ESWTユニット市場予測（～2028年）：移動式、固定式 The Erectile Dysfunction ESWT Units market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…